Fund Overlap

See which holdings any two equity ETFs have in common, along with top differences in exposure.


For overlap across multiple ETFs use Portfolio Builder   
OVERLAP
14%

OVERLAP
BY WEIGHT
11

# OF OVERLAPPING
HOLDINGS
SBIO
80
HOLDINGS
16%
ALSO IN IBRN
IBRN
58
HOLDINGS
29%
ALSO IN SBIO
SECTOR DRIFT (SBIO minus IBRN)
OVERLAPPING HOLDINGS

Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.


Company Weight
in SBIO
Weight
in IBRN
Overlap
ALKERMES PLC 3.1% 4.1% 3.1%
ACADIA PHARMACEUTICALS INC 2.9% 3.9% 2.9%
EDGEWISE THERAPEUTICS, INC. 1.7% 2.5% 1.7%
DENALI THERAPEUTICS INC. 1.6% 3.0% 1.6%
SAREPTA THERAPEUTICS INC 1.6% 3.1% 1.6%
SBIO Overweight Relative to IBRN
KYMERA THERAPEUTICS, INC. 3.8%
CRINETICS PHARMACEUTICALS INC 3.2%
CELCUITY INC. 3.2%
MIRUM PHARMACEUTICALS, INC. 2.8%
AMICUS THERAPEUTICS INC 2.8%
CG ONCOLOGY, INC. 2.8%
APOGEE THERAPEUTICS, INC. 2.7%
VIKING THERAPEUTICS, INC. 2.3%
APELLIS PHARMACEUTICALS, INC. 2.2%
IDEAYA BIOSCIENCES, INC. 2.1%
SBIO Underweight Relative to IBRN
AXSOME THERAPEUTICS, INC. -4.6%
BIOGEN IDEC INC -4.2%
PTC THERAPEUTICS INC -4.1%
SCHOLAR ROCK HOLDING CORP. -3.8%
SUPERNUS PHARMACEUTICALS INC -3.7%
ARGENX SE ADR -3.5%
NEUROCRINE BIOSCIENCES INC -3.5%
CATALYST PHARMACEUTICAL PART -3.4%
SK BIOPHARMACEUTICALS CO., LTD. -3.2%
DYNE THERAPEUTICS INC -2.5%
Flag icons made by Freepik from www.flaticon.com is licensed by CC 3.0 BY